STATE STREET CORP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 63 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,365,437
+10.5%
191,844
+10.2%
0.00%
Q2 2023$2,141,492
+244.7%
174,105
+244.4%
0.00%
Q1 2023$621,333
-44.5%
50,556
-48.3%
0.00%
Q4 2022$1,119,780
+539.9%
97,712
+109.9%
0.00%
Q3 2022$175,000
-36.8%
46,5560.0%0.00%
Q2 2022$277,000
-5.8%
46,5560.0%0.00%
Q1 2022$294,000
+61.5%
46,5560.0%0.00%
Q4 2021$182,000
-19.1%
46,5560.0%0.00%
Q3 2021$225,000
-24.2%
46,5560.0%0.00%
Q2 2021$297,000
+324.3%
46,556
+316.2%
0.00%
Q1 2021$70,000
-9.1%
11,1850.0%0.00%
Q4 2020$77,000
+71.1%
11,1850.0%0.00%
Q3 2020$45,000
+21.6%
11,1850.0%0.00%
Q2 2020$37,000
+54.2%
11,1850.0%0.00%
Q1 2020$24,000
-31.4%
11,1850.0%0.00%
Q4 2019$35,000
-30.0%
11,1850.0%0.00%
Q3 2019$50,000
-26.5%
11,1850.0%0.00%
Q2 2019$68,000
-12.8%
11,1850.0%0.00%
Q1 2019$78,000
+81.4%
11,1850.0%0.00%
Q4 2018$43,000
-61.6%
11,185
-46.6%
0.00%
Q3 2018$112,000
+14.3%
20,958
+5.1%
0.00%
Q2 2018$98,000
-94.4%
19,939
-90.9%
0.00%
Q1 2018$1,759,000
-21.9%
218,396
-0.6%
0.00%
Q4 2017$2,251,000
-31.1%
219,665
-2.4%
0.00%
Q3 2017$3,269,000225,0070.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
22NW, LP 749,302$2,892,0001.80%
Clearline Capital LP 316,425$1,221,0000.84%
Newtyn Management, LLC 888,620$3,430,0000.67%
Western Standard LLC 150,363$580,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 222,467$859,0000.40%
BVF INC/IL 721,935$2,787,0000.36%
Sepio Capital, LP 411,676$1,589,0000.12%
Yakira Capital Management, Inc. 66,934$258,0000.09%
J. Goldman & Co LP 152,095$587,0000.04%
Spark Investment Management LLC 48,909$188,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders